Clinical Trial Update: Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a standardized AHCC extract in ovarian cancer patients on adjuvant chemotherapy; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Carcinoma
• Ovarian Epithelial Carcinoma
• Peritoneal Carcinoma

Drugs mentioned

• AHCC (Active Hexose Correlated Compound)

Snippet

Sponsor: University of California, Davis | Conditions: Ovarian Epithelial Carcinoma, Fallopian Tube Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING